Postnatal and Adult Neurogenesis in the Development of Human Disease
ABSTRACT The mammalian brain contains a population of neurons that are continuously generated from late embryogenesis through adulthood-after the generation of almost all other neuronal types. This brain region-the hippocampal dentate gyrus-is in a sense, therefore, persistently immature. Postnatal and adult neurogenesis is likely an essential feature of the dentate, which is critical for learning and memory. Protracted neurogenesis after birth would allow the new cells to develop in conjunction with external events-but it may come with a price: while neurogenesis in utero occurs in a protected environment, children and adults are exposed to any number of hazards, such as toxins and infectious agents. Mature neurons might be resistant to such exposures, but new neurons may be vulnerable. Consistent with this prediction, in adult rodents seizures disrupt the integration of newly generated granule cells, whereas mature granule cells are comparatively unaffected. Significantly, abnormally interconnected cells may contribute to epileptogenesis and/or associated cognitive and memory deficits. Finally, studies increasingly indicate that new granule cells are extremely sensitive to a host of endogenous and exogenous factors, raising the possibility that disrupted granule cell integration may be a common feature of many neurological diseases.
- SourceAvailable from: Roberto Di Maio
[Show abstract] [Hide abstract]
- "Along the same lines, mRNA from surgical specimens of patients with chronic refractory TLE demonstrates significantly increased levels of NKCC1, the chloride channel associated with depolarizing GABAergic interneurons (Palma et al., 2006). While aberrant cell proliferation and differentiation may be a driver of epileptogenesis, the mechanisms linking the initial epileptic insult to changes in cell fate and differentiation remain elusive (Danzer, 2008). Given the rapid proliferation and differentiation of neural progenitor stem cells (NPSCs) throughout the immature brain, pathological effects of an inciting epileptic event on NPSCs have the potential to have a particularly profound effect on the subsequent development of TLE and other refractory epilepsies. "
ABSTRACT: While aberrant cell proliferation and differentiation may contribute to epileptogenesis, the mechanisms linking an initial epileptic insult to subsequent changes in cell fate remain elusive. Using both mouse and human iPSC-derived neural progenitor/stem cells (NPSCs), we found that a combined transient muscarinic and mGluR1 stimulation inhibited overall neurogenesis but enhanced NPSC differentiation into immature GABAergic cells. If treated NPSCs were further passaged, they retained a nearly identical phenotype upon differentiation. A similar profusion of immature GABAergic cells was seen in rats with pilocarpine-induced chronic epilepsy. Furthermore, live cell imaging revealed abnormal de-synchrony of Ca(++) transients and altered gap junction intercellular communication following combined muscarinic/glutamatergic stimulation, which was associated with either acute site-specific dephosphorylation of connexin 43 or a long-term enhancement of its degradation. Therefore, epileptogenic stimuli can trigger acute and persistent changes in cell fate by altering distinct mechanisms that function to maintain appropriate intercellular communication between coupled NPSCs.Neurobiology of Disease 07/2014; 70. DOI:10.1016/j.nbd.2014.06.020 · 5.08 Impact Factor
[Show abstract] [Hide abstract]
- "Moreover, these post-seizure born dentate granule cells exhibit accelerated maturity and functional integration into the network; receiving perforant-path input sooner than in a normal brain (Overstreet-Wadiche et al., 2006). While the continued generation of neurons in the dentate may make the region particularly vulnerable to epileptogenic rewiring (Jessberger et al., 2007; Danzer, 2008), restructuring of neuronal circuits is also evident in other brain regions. Rewiring is evident in cortical epilepsy models (for example, Graber and Prince, 2004), and histological and functional mapping studies in humans with a range of epilepsy syndromes support the conclusion that restructuring is a recurring feature of the disease (Bonilha et al., 2012; Fang et al., 2013; Woodward et al., 2013; Xu et al., 2013; Haneef et al., 2014). "
ABSTRACT: The phosphatidylinositol-3-kinase/phosphatase and tensin homolog (PTEN)-mammalian target of rapamycin (mTOR) pathway regulates a variety of neuronal functions, including cell proliferation, survival, growth, and plasticity. Dysregulation of the pathway is implicated in the development of both genetic and acquired epilepsies. Indeed, several causal mutations have been identified in patients with epilepsy, the most prominent of these being mutations in PTEN and tuberous sclerosis complexes 1 and 2 (TSC1, TSC2). These genes act as negative regulators of mTOR signaling, and mutations lead to hyperactivation of the pathway. Animal models deleting PTEN, TSC1, and TSC2 consistently produce epilepsy phenotypes, demonstrating that increased mTOR signaling can provoke neuronal hyperexcitability. Given the broad range of changes induced by altered mTOR signaling, however, the mechanisms underlying seizure development in these animals remain uncertain. In transgenic mice, cell populations with hyperactive mTOR have many structural abnormalities that support recurrent circuit formation, including somatic and dendritic hypertrophy, aberrant basal dendrites, and enlargement of axon tracts. At the functional level, mTOR hyperactivation is commonly, but not always, associated with enhanced synaptic transmission and plasticity. Moreover, these populations of abnormal neurons can affect the larger network, inducing secondary changes that may explain paradoxical findings reported between cell and network functioning in different models or at different developmental time points. Here, we review the animal literature examining the link between mTOR hyperactivation and epileptogenesis, emphasizing the impact of enhanced mTOR signaling on neuronal form and function.Frontiers in Molecular Neuroscience 03/2014; 7:18. DOI:10.3389/fnmol.2014.00018 · 4.08 Impact Factor
[Show abstract] [Hide abstract]
- "Asterisk denotes basal dendrites on immature granule cells. Scale bar = 30 μm. Figure reprinted with permission from Danzer  (Copyright © 2008 Sage Publications). Fig. 2. Normal and abnormal hippocampal dentate granule cells of pilocarpine-treated Gli1-CreER T2 × GFP reporter mice. "
ABSTRACT: Temporal lobe epilepsy in both animals and humans is characterized by abnormally integrated hippocampal dentate granule cells. Among other abnormalities, these cells make axonal connections with inappropriate targets, grow dendrites in the wrong direction, and migrate to ectopic locations. These changes promote the formation of recurrent excitatory circuits, leading to the appealing hypothesis that these abnormal cells may by epileptogenic. While this hypothesis has been the subject of intense study, less attention has been paid to the possibility that abnormal granule cells in the epileptic brain may also contribute to comorbidities associated with the disease. Epilepsy is associated with a variety of general findings, such as memory disturbances and cognitive dysfunction, and is often comorbid with a number of other conditions, including schizophrenia and autism. Interestingly, recent studies implicate disruption of common genes and gene pathways in all three diseases. Moreover, while neuropsychiatric conditions are associated with changes in a variety of brain regions, granule cell abnormalities in temporal lobe epilepsy appear to be phenocopies of granule cell deficits produced by genetic mouse models of autism and schizophrenia, suggesting that granule cell dysmorphogenesis may be a common factor uniting these seemingly diverse diseases. Disruption of common signaling pathways regulating granule cell neurogenesis may begin to provide mechanistic insight into the cooccurrence of temporal lobe epilepsy and cognitive and behavioral disorders. This article is part of a Special Issue entitled "NEWroscience 2013".Epilepsy & Behavior 01/2014; 38. DOI:10.1016/j.yebeh.2013.12.022 · 2.26 Impact Factor